{"id":839641,"date":"2025-04-07T16:12:13","date_gmt":"2025-04-07T21:12:13","guid":{"rendered":"https:\/\/newsycanuse.com\/index.php\/2025\/04\/07\/eli-lilly-launches-weight-loss-drug-in-india-what-you-should-know-about-mounjaro\/"},"modified":"2025-04-07T16:12:13","modified_gmt":"2025-04-07T21:12:13","slug":"eli-lilly-launches-weight-loss-drug-in-india-what-you-should-know-about-mounjaro","status":"publish","type":"post","link":"https:\/\/newsycanuse.com\/index.php\/2025\/04\/07\/eli-lilly-launches-weight-loss-drug-in-india-what-you-should-know-about-mounjaro\/","title":{"rendered":"Eli Lilly Launches Weight Loss Drug In India: What You Should Know About Mounjaro"},"content":{"rendered":"<div id=\"ignorediv\">\n<p>US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).<\/p>\n<p>The pharmaceutical company has launched it in a single-dose vial presentation following the marketing authorisation from CDSCO. This much-anticipated drug is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes.<\/p>\n<p>For the unversed, Mounjaro, chemically known as tirzepatide, is primarily used for controlling blood sugar levels in individuals with type-2 diabetes. Just like Novo Nordisk&#8217;s <a href=\"https:\/\/www.ndtv.com\/health\/heres-what-happens-when-you-stop-taking-ozempic-7890051\">Ozempic<\/a>, it also helps with effective <a href=\"https:\/\/www.ndtv.com\/health\/karan-johar-on-ozempic-for-weight-loss-being-healthy-eating-well-and-exercising-7892026\">weight loss<\/a>.<\/p>\n<p>Tirzepatide works by mimicking two important hormones in the body, GIP and GLP-1.<\/p>\n<p>&#8220;Historically, anti-obesity drugs have been plagued by failures, often proving ineffective or unsustainable. However, a new class of medications known as GLP-1 receptor agonists has shown remarkable promise. Originally developed for diabetes management, these drugs were later found to have profound weight-loss effects. Among them, semaglutide (sold as Ozempic and Wegovy) and tirzepatide (sold as Mounjaro) have gained significant attention,&#8221; says\u00a0<strong>Dr. Ambrish Mithal, Chairman &#038; Head &#8211; Endocrinology &#038; Diabetes, Max Healthcare.<\/strong><\/p>\n<h3>How does it work?<\/h3>\n<p>&#8220;Technically, these are Glucagon-like Peptide (GLP)-1 receptor agonists which stimulate insulin release from the pancreas and also delay emptying of food from the stomach. This causes a feeling of fullness even on eating small quantities of food and suppresses appetite. This results in weight loss and better sugar control,&#8221; explains Dr. Monica Mahajan, Director &#8211; Internal Medicine, Max Healthcare.<\/p>\n<p>By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and weight.<\/p>\n<h3>Important safety information<\/h3>\n<p>&#8220;My only concern-and I have voiced this repeatedly-is the potential for misuse. Those considering these drugs should only take them under the supervision of an endocrinologist or physician.&#8221;<\/p>\n<p>&#8220;Do not make the mistake of using them as a cosmetic drug or casually purchasing and injecting them. <strong>Remember, these drugs will be available only by prescription<\/strong>,&#8221; Dr.\u00a0Mithal told DoctorNDTV.<\/p>\n<h3>Mounjaro in India: Price, dosage and more<\/h3>\n<p>Mounjaro is a once-weekly injection available at the starting dose of 2.5 mg. A single-dose vial of 2.5 mg is priced at Rs 3,500, and the the 5 mg injection cost Rs 4,375.<\/p>\n<p>Mounjaro is a prescription-based medicine.<\/p>\n<p>&#8220;I think they are a huge advancement, and it&#8217;s very good that they will now be accessible to the Indian public at a slightly more affordable price. Previously, patients had to obtain them from abroad, where they were very expensive,&#8221; adds Dr. Mithal.<\/p>\n<p>Obesity rates in India are rising at an alarming pace, fueling an increase in diabetes, heart disease, hypertension, fatty liver disease, and related conditions. &#8220;Managing obesity has become a significant challenge, and the ultimate solution lies in prevention. It is important to focus on promoting healthy eating habits from infancy through adulthood,&#8221; Dr. Mithal\u00a0advocates.<\/p>\n<p><i>Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.<\/i><\/p>\n<\/p><\/div>\n<p> Christeen Culton<br \/><a href=\"https:\/\/news.google.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?oc=5\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO). The pharmaceutical company has launched it in a single-dose vial presentation following the marketing authorisation from CDSCO. This much-anticipated drug is a first-of-its-kind treatment for obesity, overweight, and type 2<\/p>\n","protected":false},"author":1,"featured_media":839642,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2432,1503],"tags":[7812,13350],"class_list":["post-839641","post","type-post","status-publish","format-standard","has-post-thumbnail","category-launches","category-lilly","tag-launches","tag-lilly"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/839641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/comments?post=839641"}],"version-history":[{"count":0,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/839641\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media\/839642"}],"wp:attachment":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media?parent=839641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/categories?post=839641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/tags?post=839641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}